BMEDS

Welcome to the Brand page for “BMEDS”, which is offered here for Downloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual-based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent;providing an online database featuring tracking the status of government approval of medications;providing an online database featuring medical information and diagnostics in the nature of pharmaceutical information for developing model-informed precision dosing, tracking individualized dosing, generating population based and individual based pharmacokinetic models, monitoring clinical studies, determining optimal and lowest effective dosages of medication, developing risk evaluation and mitigation strategies and surveillance system for adverse effects, and collecting real world evidence on value of therapeutic agent;creating, maintaining and hosting an interactive website for others featuring technology that enables users to enter, access, track, and generate health and medical information; creating, maintaining and hosting an interactive website for others featuring technology that enables users to manage chronic diseases, medical conditions, and health risks; creating, maintaining, and hosting an interactive website for others featuring technology that enables users to enter medical information and generate the lowest effective dosage of medication; design and development of software in the field of interactive mobile applications featuring technology that enables users to manage their optimal dosing intervals of medication; providing temporary use of nondownloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; providing temporary use of non-downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent;.

Its status is currently believed to be active. Its class is unavailable. “BMEDS” is believed to be currently owned by “Bayesian Biotech LLC”.